Skip to main content
. 2020 Feb 17;24(1):8–16. doi: 10.1080/19768354.2020.1726462

Figure 2.

Figure 2.

Strategies for delivering the CRISPR system in vivo. The CRISPR-Cas9 system can be delivered in either DNA, mRNA, or protein form in vivo, to induce gene editing. In vivo delivery methods, such as viruses, liposomes, peptides, or nanoparticles, have been developed for genome editing and can be applied to a variety of animals.